Strs Ohio Has $866,000 Stake in Cardiovascular Systems, Inc. (CSII)

Strs Ohio cut its stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 7.2% during the second quarter, Holdings Channel reports. The firm owned 26,900 shares of the medical device company’s stock after selling 2,100 shares during the period. Strs Ohio’s holdings in Cardiovascular Systems were worth $866,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of CSII. California Public Employees Retirement System raised its stake in Cardiovascular Systems by 0.6% in the first quarter. California Public Employees Retirement System now owns 31,900 shares of the medical device company’s stock valued at $902,000 after buying an additional 200 shares during the period. Chicago Equity Partners LLC raised its stake in Cardiovascular Systems by 1.0% in the first quarter. Chicago Equity Partners LLC now owns 30,890 shares of the medical device company’s stock valued at $873,000 after buying an additional 300 shares during the period. US Bancorp DE raised its stake in Cardiovascular Systems by 14.3% in the first quarter. US Bancorp DE now owns 8,708 shares of the medical device company’s stock valued at $246,000 after buying an additional 1,091 shares during the period. Winslow Evans & Crocker Inc. raised its stake in Cardiovascular Systems by 21.3% in the second quarter. Winslow Evans & Crocker Inc. now owns 6,550 shares of the medical device company’s stock valued at $210,000 after buying an additional 1,150 shares during the period. Finally, American International Group Inc. raised its stake in Cardiovascular Systems by 7.1% in the first quarter. American International Group Inc. now owns 19,619 shares of the medical device company’s stock valued at $555,000 after buying an additional 1,297 shares during the period. Hedge funds and other institutional investors own 74.82% of the company’s stock.

Cardiovascular Systems, Inc. (NASDAQ:CSII) opened at 30.17 on Friday. The firm has a 50-day moving average price of $31.61 and a 200 day moving average price of $29.73. Cardiovascular Systems, Inc. has a 12 month low of $21.29 and a 12 month high of $33.11. The company’s market capitalization is $987.49 million.

Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings data on Wednesday, August 2nd. The medical device company reported $0.02 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.07. Cardiovascular Systems had a positive return on equity of 0.89% and a negative net margin of 0.87%. The company had revenue of $52.90 million during the quarter, compared to analysts’ expectations of $51.98 million. During the same period last year, the firm posted ($0.15) earnings per share. The business’s revenue was up 9.1% on a year-over-year basis. Analysts expect that Cardiovascular Systems, Inc. will post $0.01 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/08/18/strs-ohio-has-866000-stake-in-cardiovascular-systems-inc-csii.html.

Several research firms recently weighed in on CSII. Needham & Company LLC restated a “buy” rating and issued a $37.00 target price (up from $32.00) on shares of Cardiovascular Systems in a report on Friday, July 14th. Zacks Investment Research lowered Cardiovascular Systems from a “hold” rating to a “sell” rating in a report on Friday, August 4th. TheStreet upgraded Cardiovascular Systems from a “d” rating to a “c-” rating in a report on Thursday, May 4th. BidaskClub lowered Cardiovascular Systems from a “buy” rating to a “hold” rating in a report on Thursday, July 13th. Finally, Bank of America Corporation lowered Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a report on Wednesday, June 21st. Three research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $33.83.

In other news, COO Kevin J. Kenny sold 4,733 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $30.74, for a total value of $145,492.42. Following the completion of the sale, the chief operating officer now directly owns 153,339 shares of the company’s stock, valued at $4,713,640.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Laurence L. Betterley sold 4,443 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $30.74, for a total value of $136,577.82. Following the completion of the sale, the chief financial officer now directly owns 223,557 shares of the company’s stock, valued at $6,872,142.18. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 10,155 shares of company stock valued at $312,135. Insiders own 3.60% of the company’s stock.

About Cardiovascular Systems

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

What are top analysts saying about Cardiovascular Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardiovascular Systems Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit